Healthcare >> CEO Interviews >> October 12, 2001
KENNETH W. FREEMAN is Chairman and CEO of Quest Diagnostics
Incorporated. Mr. Freeman began his career in 1972 as an Internal
Auditor at Corning Incorporated. For the next 15 years he progressed
through Corning's financial function. He was elected Vice President and
Corporate Controller in 1985, and named Senior Vice President in 1987.
Mr. Freeman was appointed General Manager of the Science Products
Division in 1989, and President and CEO of Corning Asahi Video Products
Company in 1990. In 1993, he was appointed Executive Vice President of
Corning Incorporated. In May 1995, Mr. Freeman was appointed President
and CEO of Corning Clinical Laboratories. In January 1997, when the
business was spun-off to Corning's shareholders as Quest Diagnostics
Incorporated, he was appointed Chairman, President and CEO. Mr. Freeman
holds a Bachelor of Science degree from Bucknell University and an MBA
degree from Harvard University. He is a member of the Board of Directors
of TRW, Inc., and the American Clinical Laboratory Association, and a
trustee of Bucknell University. Profile
investors should focus on?
Mr. Freeman: We've come a long way in the last year. As you know, we
acquired one of our
